Profile

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Company Name	Adagio Medical Holdings, Inc.	Abbott Laboratories	Boston Scientific Corporation	Boston Scientific Corporation	Stryker Corporation	Medtronic plc
Sector	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare
Industry	Medical - Devices	Medical - Devices	Medical - Devices	Medical - Devices	Medical - Devices	Medical - Devices
Market Cap	$19.53M	$239.05B	$175.45B	$154.29B	$143.53B	$110.15B
Employees	0.08K	114.00K	45.00K	53.00K	53.00K	95.00K
CEO	Todd Usen	Robert B. Ford	Mr. Michael F. Mahoney	Michael F. Mahoney	Mr. Kevin A. Lobo	Geoffrey Straub Martha

Ratings

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Quant Rating Score	1	4		3	3	3
Quant Rating	Strong Sell	Buy		Neutral	Neutral	Neutral

Trading

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Last Close	$1.27	$137.4	$122.18	$104.29	$392.23	$85.97
High 52	$8.17	$140.22	$122.18	$106.66	$399.9	$94.5
Low 52	$0.74	$100.07	$122.18	$72.96	$315.94	$76.84
Price vs. 52 Week High	-84.46 %	-2.01 %	0 %	-2.22 %	-1.92 %	-9.03 %
Price vs. 52 Week Low	71.62 %	37.3 %	0 %	42.94 %	24.15 %	11.88 %

Total Return

	ADGM	ABT	BSX	SYK	MDT
1 Month Return	6.72 %	4.65 %	-0.2 %	4.14 %	6.56 %
3 Month Return	35.84 %	8.52 %	1.91 %	6.65 %	-2.56 %
6 Month Return	19.81 %	19.2 %	14.04 %	6.17 %	5.36 %
9 Month Return	-62.87 %	21.88 %	25.53 %	8.55 %	-3.89 %
YTD Return	20.95 %	21.47 %	16.76 %	8.94 %	7.62 %
1 Year Return	0 %	31.01 %	35.27 %	15.19 %	7.4 %
3 Year Return	0 %	0 %	0 %	0 %	0 %
5 Year Return	0 %	0 %	0 %	0 %	0 %

Dividends

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Dividend Yield Percentage (TTM)	-	1.66 %	-	-	0.87 %	3.26 %
Dividend Paid and Capex Coverage Ration (TTM)	-55.08 %	1.57 %	3.96 %	3.96 %	2.2 %	1.29 %
Dividend Per Share (TTM)	-	2.28 %	-	-	3.28 %	2.8 %
Payout Ratio (TTM)	-	28.92 %	1.13 %	1.13 %	43.2 %	76.97 %

Growth

	ADGM	ABT	BSX-PA	BSX
Asset Growth	609.86 %	11.2 %	12.12 %	-1.06 %
Gross Profit Growth	-65.81 %	5.01 %	16.12 %	3.12 %
Revenue Growth	-10.33 %	4.59 %	17.61 %	3.64 %
Revenue 3 Year	25.77 %	-0.18 %	36.16 %	8.85 %
Revenue 5 Year	-	34.24 %	47.52 %	7.41 %
Revenue 10 Year	-	80.43 %	104.22 %	43.65 %
EBIT Growth	-96.36 %	3.71 %	14.98 %	-7.4 %
Net Income Growth	-40.94 %	134.18 %	16.38 %	-2.18 %
Net Income 3 Yeari Growth Per Share	-934.33 %	94.27 %	72.14 %	3.26 %
Net Income 5 Yeari Growth Per Share	-501202.18 %	271.11 %	-62.7 %	-19.5 %
Net Income 10 Yeari Growth Per Share	-501202.18 %	410.99 %	524.92 %	-9.48 %
Operating Income Growth	-123.61 %	5.36 %	11.1 %	-6.22 %
Operating Cash Flow Growth (CFG)	37.67 %	17.86 %	37.24 %	12.39 %
Operating 3 Year CFG	-4.55 %	-16.72 %	77.55 %	10.18 %
Operating 5 Year CFG	-	42.4 %	76.92 %	-1.78 %
Operating 10 Year CFG	-	102.79 %	143.61 %	3.3 %
EPS Growth	27.16 %	134.55 %	16.67 %	-2.12 %
EPS Diluted Growth	27.16 %	133.64 %	16.82 %	-2.13 %
Book Value Per Share	124.44 %	23.54 %	11.25 %	-2.26 %
Share Holder 3 Year Equity Growth Per Share	-81.94 %	36.46 %	26.58 %	-1.1 %
Share Holder 5 Year Equity Growth Per Share	185765.4 %	56.53 %	48.35 %	1.66 %
Share Holder 10 Year Equity Growth Per Share	185765.4 %	92.83 %	186.31 %	94.93 %
Dividend Per Share Growth	-	8.02 %	-100 %	1.54 %
Dividend 3 Year Growth Per Share	-	22.8 %	-100 %	19.02 %
Dividend 5 Year Growth Per Share	-	72.53 %	-	38.05 %
Dividend 10 Year Growth Per Share	-	148.92 %	-	147.94 %
Debt Growth	-59.29 %	-5.37 %	17.44 %	6.91 %
Free Cash Flow Growth	37.07 %	25.54 %	55.31 %	13.54 %
Updated On	31 Dec 2024	31 Dec 2024	31 Dec 2024	26 Apr 2024

Profitability

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Gross Profit Margin TTM	-620.99 %	55.89 %	67.15 %	67.15 %	63.57 %	64.06 %
Return on Assets TTM	-148.12 %	16.58 %	5.06 %	5.06 %	6.21 %	5.09 %
Return on Equity TTM	-224.96 %	30.76 %	9.56 %	9.56 %	10.73 %	9.62 %
Return on Capital Employed TTM	-196.04 %	10.5 %	8.77 %	8.77 %	9.61 %	7.56 %
Net Income Per EBT TTM	100 %	183.58 %	81.97 %	81.97 %	85.78 %	82.85 %
EBT Per Ebit TTM	88.4 %	102.35 %	80.59 %	80.59 %	91.04 %	94.51 %
EBIT Per Revenue TTM	-28504.22 %	16.97 %	17.52 %	17.52 %	15.77 %	17.76 %
Cash Flow To Debt Ratio TTM	-160.36 %	67.59 %	32.56 %	32.56 %	29.81 %	24.7 %
Receivables Turnover TTM	243	4.38	6.52	6.52	5.86	5.15
Payables Turnover TTM	0.62	4.43	5.74	5.74	-	4.74
Inventory Turnover TTM	0.71	2.81	2.01	2.01	1.66	2.12
Fixed Asset Turnover TTM	8.05 %	387.34 %	517.94 %	517.94 %	656.62 %	490.52 %
Asset Turnover TTM	0.59 %	51.99 %	43.73 %	43.73 %	50.47 %	36.58 %
Operating Cash Flow Per Share TTM	-1.94	5.12	2.58	2.58	11.23	5.49
Free Cash Flow Per Share TTM	-1.51	3.81	1.94	1.94	9.37	4.04
Cash Per Share TTM	84.31 %	391.71 %	49.08 %	49.08 %	631.12 %	699.13 %
Operating Cash Flow Sales Ratio TTM	-12263.5 %	21.14 %	21.72 %	21.72 %	18.47 %	21 %
Free Cash Flow Operating Cash Flow Ratio TTM	77.95 %	74.38 %	75.37 %	75.37 %	83.42 %	73.61 %
Cash Flow Coverage Ratios TTM	-160.36 %	67.59 %	32.56 %	32.56 %	29.81 %	24.7 %
Price To Free Cash Flows Ratio TTM	-0.84	35.91	53.62	53.7	40.12	21.24
Price To Operating Cash Flows Ratio TTM	-0.66	26.82	40.35	40.41	33.43	15.65
Price Cash Flow Ratio TTM	-0.66	26.82	40.35	40.41	33.43	15.65

Income Statement (TTM)

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Revenue	$0B	$41.95B	$16.75B	$16.75B	$22.6B	$33.54B
Gross Profit	$-0B	$23.24B	$11.49B	$11.49B	$14.44B	$21.97B
Gross Profit Ratio	-620.07%	55.41%	68.61%	68.61%	63.91%	65.51%
EBITDA	$-0.06B	$10.83B	$3.94B	$3.94B	$5.72B	$5.96B
Net Income	$-0.05B	$13.4B	$1.85B	$1.85B	$2.99B	$4.66B
EPS Diluted	-3.54	7.64	1.25	1.25	7.76	3.61

Balance Sheet (MRQ)

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Long Term Debt	$0.02B	$13.52B	$8.84B	$8.84B	$12.19B	$25.64B
Total Liabilities	$0.03B	$33.51B	$17.39B	$17.39B	$22.34B	$43.42B
Total Equity	$0.02B	$47.9B	$22B	$22B	$20.63B	$48.26B
Total Investments	$0B	$1.24B	$0.56B	$0.56B	$0.84B	$6.75B
Total Debt	$0.02B	$15.02B	$11.15B	$11.15B	$13.6B	$28.52B
Total Assets	$0.05B	$81.41B	$39.4B	$39.4B	$42.97B	$91.68B

Cash Flow Statement (TTM)

	ADGM	ABT	BSX-PA	BSX	SYK	MDT
Net Income	$-0.02B	$13.4B	$1.85B	$1.85B	$2.99B	$4.69B
Inventory	$0B	$-0.06B	$-0.23B	$-0.23B	$0.05B	$-0.29B
Dividends Paid	$0B	$-3.84B	$0B	$0B	$-1.22B	$-3.59B
Operating Cash Flow	$-0.02B	$8.56B	$3.44B	$3.44B	$4.24B	$7.04B
Capital Expenditure	$-0B	$-2.21B	$-0.79B	$-0.79B	$-0.76B	$-1.86B

Related Stocks

Ticker	Name	Price
ABMD	Abiomed, Inc.	381.02
ABT	Abbott Laboratories	133.69
AEMD	Aethlon Medical, Inc.	1.86
AFIB	Acutus Medical, Inc.	0.0018
AHCO	AdaptHealth Corp.	9.415
AHPI	Allied Healthcare Products, Inc.	0.004
ALGN	Align Technology, Inc.	187.83
ALUR	Allurion Technologies Inc.	2.49
AMIX	Autonomix Medical, Inc. Common Stock	1.24
ANIK	Anika Therapeutics, Inc.	10.84
AORT	Artivion, Inc.	30.58
APEN	Apollo Endosurgery, Inc.	10
APYX	Apyx Medical Corporation	2.215
ASXC	Asensus Surgical, Inc.	0.3479
ATEC	Alphatec Holdings, Inc.	10.89
AVNS	Avanos Medical, Inc.	12.15
AVR	Anteris Technologies Global Corp. Common Stock	4
AXDX	Accelerate Diagnostics, Inc.	0.034
AXGN	AxoGen, Inc.	10.485
AXNX	Axonics, Inc.	70.98

Unlock

Fidelitey